Clinical trials: Legionnaires' Disease
Legionnaires' Disease
Severe Legionellosis Cases Admitted to Grenoble University Hospital, 2006-2011.
The study aimed at further describing the epidemiological, clinical, diagnostic and prognostic features in legionellosis cases admitted to Grenoble University Hospital during the 2006-2011period.
- Trial name
- LEGIOGRE (NCT02884700)
- Testing
- Real-time PCR testing of lower respiratory tract samples
- Volunteers
- 82 people
- Sponsor
- University Hospital, Grenoble
Respiratory Infections, COVID-19
Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath
Emerging respiratory diseases represent a global threat. Viruses such as influenza and coronaviruses have been the main drivers of pandemics over the past century.
- Conditions
- Respiratory Infections, COVID-19, Influenza Virus Infection, Legionella Pneumophila Infections
- Trial name
- VORTEX-2 (NCT07352462)
- Testing
- Volatile Organic compounds (VOC) analysis in Exhaled breath using GC-MS
- Where
- 7 sites in France
- Volunteers
- 777 people, healthy volunteers welcome
- Sponsor
- Hospices Civils de Lyon
Legionella Pneumophila Pneumonia
Impact of Legionella Urine Antigen Testing (LUAT) on the Local Epidemiology and Diagnosis of Legionella Pneumonia
There has never been a paper published or research done to determine the rate of Legionella species as a cause of community or nosocomial acquired pneumonia requiring hospitalization in Malaysia.
- Trial name
- NCT03200275
- Testing
- Immunocatch™ Legionella Urine Antigen Test
- Where
- Malaysia
- Volunteers
- 505 people
- Sponsor
- Ministry of Health, Malaysia
Legionellosis
Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis
The validity of molecular techniques for the diagnosis of legionellosis is not known. Although PCR can detect Legionella pneumophila (responsible for 80% of legionellosis) and other Legionella species, this test is not…
- Trial name
- NCT00452153
- Testing
- Characterization Legionnella
- Where
- 6 sites in France
- Volunteers
- 200 people
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Legionella
Bacterial and Human Biomarkers of Prognostic Value for Severe Legionnaire's Disease
Legionnaires' disease (LD) is a relatively common pneumonia in France (1200 cases/year), 98% of cases are hospitalized and 40% require intensive care unit (ICU) admission.
- Trial name
- Proglegio (NCT03064737)
- Testing
- Skin biopsy for genetic analyze
- Where
- 19 sites in France
- Volunteers
- 300 people
- Sponsor
- Hospices Civils de Lyon
Community Acquired Pneumonia
Community Acquired Pneumonia in Telemark and Ostfold
The aim of the study is to investigate the bacterial causes in community acquired pneumonia in adults admitted to hospital in two counties in Norway and to look at possible factors that makes the patients susceptible to pneumonia.
- Trial name
- CAPITO (NCT00467701)
- Where
- Norway
- Volunteers
- 380 people
- Sponsor
- Sykehuset Telemark
Legionnaires' Disease
Legionnaires' Effect on Smell
The goal of this study is to determine whether survivors of Legionnaires' disease suffer smell loss. A quantitative olfactory test will be performed by the participants.
- Trial name
- NCT03321786
- Testing
- The University of Pennsylvania Smell Identification Test (UPSIT)
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Pennsylvania
Legionnaires' Disease
Nosocomial and Community Acquired Legionella Pneumophila Pneumonia.
Legionnaire's disease (LD) is a major cause of both community acquired and nosocomial pneumonia, with Legionella pneumophila serogroup A (Lp1) being the most virulent and the greatest cause of disease.
- Trial name
- NCT04106037
- Testing
- Data extraction from medical files
- Where
- 3 sites in Belgium
- Volunteers
- 46 people
- Sponsor
- Dr Philippe CLEVENBERGH
Legionnaires' Disease, Legionella Pneumophila Infections
Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
To collect retrospectively the efficacy and safety information of azithromycin IV on patients with Legionnaires' disease related to their appropriate use in daily practice.
- Trial name
- RESCUE-L (NCT01784770)
- Testing
- Azithromycin IV
- Volunteers
- 21 people
- Sponsor
- Pfizer